financetom
Business
financetom
/
Business
/
General Mills Reports Better-Than-Expected Fiscal First-Quarter Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
General Mills Reports Better-Than-Expected Fiscal First-Quarter Results
Sep 22, 2024 1:24 PM

09:17 AM EDT, 09/18/2024 (MT Newswires) -- General Mills' ( GIS ) fiscal first-quarter results declined less than market expectations year over year, while the Cheerios maker reiterated its full-year outlook.

The company's adjusted earnings slipped to $1.07 a share for the quarter ended Aug. 25 from $1.09 the year before, but topped the Capital IQ-polled consensus of $1.06. Sales fell 1% year over year to $4.85 billion, ahead of the Street's view for $4.8 billion. Organic net sales were also down 1% amid unfavorable organic net price realization and mix.

"Our top priority in fiscal 2025 is to accelerate our organic net sales growth, and we made expected progress on that goal in the first quarter along multiple fronts," Chief Executive Jeff Harmening said in a statement. "We strengthened our core by delivering more remarkable experiences to consumers, which translated into improved volume, net sales, and market share trends versus the previous quarter."

North America retail sales decreased 2% to $3.02 billion due to lower pound volume, which was partially offset by higher prices. Revenue was down by mid-single digit in the US snacks operating unit and low-single digit for US morning foods. North American foodservice sales were nearly flat year over year at $536.2 million.

Pet sales in North America came in at $576.1 million, down from $579.9 million in the prior-year quarter. The segment logged mid-single-digit and low-single-digit declines in net sales for pet treats and wet pet food, respectively, while dry pet food was flat.

International revenue edged higher to $717 million from $715.8 million last year, despite lower prices and a two-point foreign exchange headwind.

The packaged foods maker continues to project adjusted EPS to be down 1% to up 1% in constant currency for fiscal 2025. Full-year organic sales are still anticipated to range between flat and up 1%. The Street is looking for normalized EPS of $4.50 and revenue of $19.92 billion for the fiscal year.

"Looking ahead, we'll continue to work to improve our competitiveness and get back to leading growth in our categories," according to Harmening. "Having delivered expected improvement in (the first quarter), we are reaffirming our full-year outlook for fiscal 2025."

Price: 72.60, Change: -1.90, Percent Change: -2.55

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Invesco's Q1 Adjusted Earnings Fall, Operating Revenue Rises
Invesco's Q1 Adjusted Earnings Fall, Operating Revenue Rises
Apr 23, 2024
07:55 AM EDT, 04/23/2024 (MT Newswires) -- Invesco ( IVZ ) reported Q1 adjusted earnings Tuesday of $0.33 per diluted share, down from $0.38 a year earlier. Analysts polled by Capital IQ expected $0.40. Operating revenue for the quarter ended March 31 was $1.48 billion, up from $1.42 billion a year earlier. Analysts surveyed by Capital IQ expected $1.08 billion...
Lockheed Martin Fiscal Q1 Adjusted Earnings Drop, Net Sales Advance; Fiscal 2024 Outlook Reiterated
Lockheed Martin Fiscal Q1 Adjusted Earnings Drop, Net Sales Advance; Fiscal 2024 Outlook Reiterated
Apr 23, 2024
07:54 AM EDT, 04/23/2024 (MT Newswires) -- Lockheed Martin ( LMT ) reported fiscal Q1 adjusted earnings Tuesday of $6.33 per diluted share, down from $6.43 a year earlier. Analysts polled by Capital IQ expected $5.86. Net sales for the quarter ended March 31 were $17.2 billion, up from $15.13 billion a year earlier. Analysts surveyed by Capital IQ expected...
Quest Diagnostics raises 2024 profit and revenue forecast on strong demand
Quest Diagnostics raises 2024 profit and revenue forecast on strong demand
Apr 23, 2024
April 23 (Reuters) - Laboratory operator Quest Diagnostics ( DGX ) raised its 2024 profit and revenue forecast on Tuesday after beating first-quarter estimates on robust demand for its diagnostic tests. Demand for routine diagnostic health checkups has grown over the past few quarters as more people undergo non-urgent surgeries that were delayed due to the pandemic. Our investments within...
ZYUS Life Sciences Receives US Patent for Pain Management Drug Candidate
ZYUS Life Sciences Receives US Patent for Pain Management Drug Candidate
Apr 23, 2024
07:53 AM EDT, 04/23/2024 (MT Newswires) -- ZYUS Life Sciences ( ZLSCF ) , which is developing cannabinoid-based pharmaceutical drug candidates for pain management, on Tuesday said the United States Patent and Trademark Office issued the company a patent for its lead drug candidate, Trichomylin softgel capsules. This is the seventh patent in this patent family, joining other jurisdictions such...
Copyright 2023-2026 - www.financetom.com All Rights Reserved